EGCG
Best for
Lose weight on the scale
Large effect, needs confirmation · 379–1970 mg/day for 6–12 weeks · 3 studies , n=250
32 papers · 9 claims · 108 outcomes scored · 8 positive
Outcomes
What egcg actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Less weight on your joints, better blood markers, easier movement.
Your body favors fat as fuel, sparing stored carbs for intense efforts.
Targets the visceral fat that wraps around your organs and drives inflammation.
Your skin tolerates more UV before reddening, backing up your sunscreen.
Less oxidative damage to your cell membranes, proteins, and DNA.
You lose inches around your waist, hips, or arms as fat drops.
Keeps you feeling done after eating instead of circling back to the kitchen.
Body fat percentage drops and the mirror shows it before the scale does.
Genuine satiety replaces the constant urge to snack or overeat.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Lose weight on the scale Large effect, needs confirmation | | 3 RCTs n=250 | 379–1970 mg | 6–12 wk | #1/75 |
| Burn more fat for fuel Promising early signal | | 4 RCTs n=130 | 250–1450 mg | 0–0 wk | #8/18 |
| Reduce belly and deep abdominal fat Promising early signal | | 2 RCTs n=46 | 379–856.8 mg | 6–12 wk | #3/51 |
| Raise sunburn threshold Promising early signal | | 1 meta-analysis n=28 Meta-analyzed | — | — | #1/2 |
| Reduce oxidative cell damage Faint early signal | | 4 RCTs n=389 | 5.4–843 mg | 12–52 wk | — |
| Shrink waist and hip measurements Likely modest benefit | | 1 RCT n=146 | 856.8 mg | 6 wk | #1/13 |
| Calm hunger signals after meals Not enough research | | 2 RCTs n=146 | 856.8–1315 mg | 6–52 wk | #2/4 |
| Lose body fat Not enough research | | 1 RCT n=58 | 1350–1970 mg | 12 wk | #7/56 |
| Feel full longer and crave less Not enough research | | 1 RCT n=— | 1315 mg | 52 wk | — |
Risk profile
Adverse events and known drug interactions
Safety events
Sources
- 1. Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial. (2018) ↑
- 2. Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. (2012) ↑
- 3. Long-Term Green Tea Supplementation Does Not Change the Human Gut Microbiota. (2016) ↑
- 4. Green Tea Catechin Association with Ultraviolet Radiation-Induced Erythema: A Systematic Review and Meta-Analysis. (2021) ↑
- 5. Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans. (2010) ↑
- 6. Green Tea, Intermittent Sprinting Exercise, and Fat Oxidation. (2015) ↑
- 7. The polyphenol epigallocatechin gallate lowers circulating catecholamine concentrations and alters lipid metabolism during graded exercise in man: a randomized cross-over study. (2023) ↑
- 8. A 3-day EGCG-supplementation reduces interstitial lactate concentration in skeletal muscle of overweight subjects. (2015) ↑
- 9. The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial. (2016) ↑
- 10. The Effects of Green Tea Extract on Working Memory in Healthy Women. (2018) ↑
Generated August 14, 2026
Related
More evidence for EGCG
Evidence guide
EGCG (epigallocatechin gallate)
NewFrom Monk's Bowl to Molecule: How EGCG Walked Out of Tea and Into Modern Medicine
Evidence guide
Apr 1, 2026
Evidence map
Focus & memory
NewFocus & memory: evidence map across 45 supplements
Evidence coverage map
Jul 30, 2026
Evidence map
Metabolic health
NewMetabolic health: evidence map across 82 supplements
Evidence coverage map
Jul 30, 2026